Customized Peptide Synthesis Market Growth Factors, Applications, Regional Analysis, Key Players and Forecasts by 2024

Posted on 2019-07-29 by P&S Intelligence in Healthcare // 0 Comments

New York, United States, 2019-Jul-29 — /EPR Network/ —

The customized peptide synthesis market is projected to generate a revenue of $390.0 million by 2024 as per a recent P&S Intelligence study. The market is being progressively driven by technological innovations, growing burden of cancer and infectious diseases, increasing investments and funding for protein-based research, and rising research activities in synthetic biology.

Download free report sample at: http://bit.ly/2SKqfOc

There are two main types of products available in the customized peptide synthesis market: reagents and equipment. Among the two, the reagents category is expected to witness the faster growth during the forecast period, registering a CAGR of 6.8%. The reason for such a growth of the domain would be the heavy usage of a wide variety of reagents, including additives, substrates, precipitation agents, buffers, and others.

Now talking about the application segment, commercial application is expected to be the fastest growing in the customized peptide synthesis market during the forecast period, registering a CAGR of 6.9%. The inclusion of modified amino acids and recent advancements in chemical peptide synthesis have expanded the commercial potential of customized peptides. Moving further to the technology segment, the solid-phase peptide synthesis (SPPS) technology is projected to gain the most ground during 2019–2024, advancing at a CAGR of 6.9%.

Browse full report at: http://bit.ly/2I6ponf

Such significant discoveries based on intensive research are projected to help in the growth of the customized peptide synthesis market in Asia-Pacific (APAC). During the forecast period, the market in APAC is predicted to advance at a CAGR of 7.9%. The growth would be mainly driven by low raw material prices, technological advancements, increasing research activities in life sciences, rising use of peptides in drug discovery, and availability of funds for research and development.

Some of the other key players operating in the customized peptide synthesis industry are GenScript Biotech Corporation, Bachem AG, Thermo Fisher Scientific Inc., AAPPTec LLC, Advanced ChemTech, AnaSpec Inc., New England Peptide Inc., Rockland Immunochemicals Inc., INTAVIS Bioanalytical Instruments AG, and JPT Peptide Technologies GmbH.

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Matched content

Editor’s pick